| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 545.63B | 555.52B | 536.44B | 487.41B | 418.34B |
| Gross Profit | 313.84B | 315.00B | 296.22B | 263.21B | 220.67B |
| EBITDA | 121.08B | 106.63B | 81.00B | 54.22B | 36.82B |
| Net Income | 76.09B | 52.81B | 55.58B | 32.38B | 12.34B |
Balance Sheet | |||||
| Total Assets | 1.22T | 1.21T | 1.23T | 1.22T | 1.17T |
| Cash, Cash Equivalents and Short-Term Investments | 75.27B | 42.76B | 73.58B | 106.55B | 85.25B |
| Total Debt | 68.23B | 94.02B | 124.55B | 170.24B | 178.74B |
| Total Liabilities | 597.82B | 602.85B | 624.28B | 664.79B | 650.91B |
| Stockholders Equity | 619.22B | 601.89B | 594.42B | 547.01B | 512.91B |
Cash Flow | |||||
| Free Cash Flow | 65.83B | 68.19B | 35.33B | 53.43B | 18.76B |
| Operating Cash Flow | 90.66B | 89.56B | 56.90B | 66.30B | 37.91B |
| Investing Cash Flow | 21.63B | -25.95B | -27.02B | -27.03B | -17.37B |
| Financing Cash Flow | -76.92B | -94.91B | -68.48B | -16.20B | -39.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥1.30T | 17.26 | 9.37% | 2.59% | -1.78% | 50.76% | |
69 Neutral | ¥638.30B | 20.51 | 7.58% | 2.58% | 0.73% | -29.62% | |
69 Neutral | ¥73.08B | 18.80 | ― | 1.09% | 8.99% | 5.35% | |
68 Neutral | ¥318.99B | 8.31 | 4.97% | 2.01% | -0.23% | -16.92% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥635.43B | -80.53 | 9.06% | 1.84% | -1.23% | -124.02% | |
48 Neutral | ¥81.03B | 35.09 | ― | 0.83% | -5.02% | -4.83% |